打印

作者

来源

EUROPEAN URBAN AND REGIONAL STUDIES,Vol.25,Issue4,P.405-422

语言

英文

关键字

Healthcare; innovation cycles; innovation geographies; public policy; regional development; BIOTECHNOLOGY INDUSTRY; REGIONAL ECONOMIES; SYSTEMS; DYNAMICS; CLUSTER; DESIGN; IMPACT; POLICY

作者单位

[Smith, Helen Lawton] Birkbeck Univ London, London, England. [Bagchi-Sen, Sharmistha] SUNY Buffalo, Buffalo, NY USA. [Edmunds, Laurel] Univ Oxford, Oxford, England. Smith, HL (reprint author), Birkbeck Univ London, Dept Management, Malet St, London WC1E 7HX, England. E-Mail: h.lawton-smith@bbk.ac.uk

摘要

This paper examines place-specific factors affecting geographies of innovation, that is, the transfer of research from the laboratory to bedside in the healthcare sector in four European bioscience regions. These regions are Medical Delta (MD; Leiden, Rotterdam and Delft, Netherlands) Oxford and the Thames Valley (OTV; UK), Biocat (Catalonia, Spain) and Life Science Zurich (LSZ; Switzerland). Evidence is drawn from the European Union-funded Healthcare Technology and Innovation for Economic Success (HealthTIES) project (2010-2013). The analytical framework, the HealthTIES Innovation Cycle, is organised into resources (inputs), innovation system elements and outcomes. The paper shows that each region represents different positions within international value chains of innovation in the healthcare sector. They range from the highly research intensive but with relatively less in the way of commercial exploitation location (OTV) to the less research intensive but with more commercialisation (LSZ).